The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure
Abstract
BACKGROUND: We tested the hypothesis that prophylactic cardiac-resynchronization therapy in the form of biventricular stimulation with a pacemaker with or without a defibrillator would reduce the risk of death and hospitalization among patients with advanced chronic heart failure and intraventricular conduction delays. METHODS: A total of 1520 patients who had advanced heart failure (New York Heart Association class III or IV) due to ischemic or nonischemic cardiomyopathies and a QRS interval of at least 120 msec were randomly assigned in a 1:2:2 ratio to receive optimal pharmacologic therapy (diuretics, angiotensin-converting-enzyme inhibitors, beta-blockers, and spironolactone) alone or in combination with cardiac-resynchronization therapy with either a pacemaker or a pacemaker-defibrillator. The primary composite end point was the time to death from or hospitalization for any cause. RESULTS: As compared with optimal pharmacologic therapy alone, cardiac-resynchronization therapy with a pacemaker decreased the risk of the primary end point (hazard ratio, 0.81; P=0.014), as did cardiac-resynchronization therapy with a pacemaker-defibrillator (hazard ratio, 0.80; P=0.01). The risk of the combined end point of death from or hospitalization for heart failure was reduced by 34 percent in the pacemaker group (P<0.002) and by 40 percent in the pacemaker-defibrillator group (P<0.001 for the comparison with the pharmacologic-therapy group). A pacemaker reduced the risk of the secondary end point of death from any cause by 24 percent (P=0.059), and a pacemaker-defibrillator reduced the risk by 36 percent (P=0.003). CONCLUSIONS: In patients with advanced heart failure and a prolonged QRS interval, cardiac-resynchronization therapy decreases the combined risk of death from any cause or first hospitalization and, when combined with an implantable defibrillator, significantly reduces mortality.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While clinical improvements are generally achieved, six-month nonresponder rates have been reported to be as high as 32–43%11,13, which is partially attributed to anatomic constraints of lead positioning14.”
From Synchronized Biventricular Heart Pacing in a Closed-chest Porcine Model based on Wirelessly Powered Leadless Pacemakers (2020) · cites this paper as [13]
In the citing paper
“Device therapies (implantable cardioverter defibrillator [ICD], cardiac resynchronization therapy [CRT], and CRT with an implantable defibrillator [CRT-D]) have similar efficacies and risks in patients with HFrEF with or without diabetes.[522][523][524][525]”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [524]
Citations
Cites
Moss, A. J., Zareba, W., Hall, W. J., Klein, H., Wilber, D. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Brown, M. W., & Andrews, M. L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013474 · Cited by 6,902
Cardiac Resynchronization in Chronic Heart Failure
Abraham, W. T., Fisher, W. G., Smith, A. L., Delurgio, D. B., Leon, A. R., Loh, E., Kocovic, D. Z., Packer, M., Clavell, A. L., Hayes, D. L., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013168 · Cited by 4,648
CARDIAC RESYNCHRONIZATION IN CHRONIC HEART FAILURE
Braham, W. I. T. A., Isher, W. E. G. F., Mith, L. S., Elurgio, D. A. B. D., Eon, A. N. R. L., Oh, E., Ocovic, D. U. Z. K., Acker, M. G., Lavell, L. C., Ayes, D. A. L. H., et al. (2002) · Cited by 3,808
A Multiple Testing Procedure for Clinical Trials
O'Brien, P. C., & Fleming, T. R. (1979) · Biometrics · doi:10.2307/2530245 · Cited by 3,311
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310
Self-citationDiscrete Sequential Boundaries for Clinical Trials
Lan, K. K. G., & DeMets, D. L. (1983) · Biometrika · doi:10.2307/2336502 · Cited by 2,310
Self-citationSt John Sutton, M. G., Plappert, T., Abraham, W. T., Smith, A. L., DeLurgio, D. B., Leon, A. R., Loh, E., Kocovic, D. Z., Fisher, W. G., Ellestad, M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000065226.24159.e9 · Cited by 1,124
Auricchio, A., Stellbrink, C., Sack, S., Block, M., Vogt, J. Ü., Bakker, P., Huth, C., Schöndube, F., Wolfhard, U., Böcker, D., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01895-8 · Cited by 1,026
Linde, C., Leclercq, C., Rex, S., Garrigue, S., Lavergne, T., Cazeau, S., McKenna, W., Fitzgerald, M., Deharo, J.-C., Alonso, C., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01932-0 · Cited by 973
Baldasseroni, S., Opasich, C., Gorini, M., Lucci, D., Marchionni, N., Marini, M., Campana, C., Perini, G., Deorsola, A., Masotti, G., et al. (2002) · American Heart Journal · doi:10.1067/mhj.2002.121264 · Cited by 800
Cited by
Items 801–900 of 1,014
Rinaldi, C. A., Kranig, W., Leclercq, C., Kacet, S., Betts, T. R., Bordachar, P., Gutleben, K., Shetty, A., Keel, A. J., Ryu, K., et al. (2013) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2013.10.003 · Cited by 61
Maďarič, J., Vanderheyden, M., Laethem, C. V., Verhamme, K. M. C., Feys, A., Goethals, M., Verstreken, S., Geelen, P., Pěnička, M., Bruyne, B. D., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm126 · Cited by 60
Influence of Pacing Site Characteristics on Response to Cardiac Resynchronization Therapy
Wong, J. A., Yee, R. K., Stirrat, J., Scholl, D., Krahn, A. D., Gula, L. J., Skanes, A. C., Leong‐Sit, P., Klein, G. J., McCarty, D., et al. (2013) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.111.000146 · Cited by 63
Does Cardiac Resynchronization Therapy Benefit Patients With Right Bundle Branch Block
Auricchio, A., Lumens, J., & Prinzen, F. W. (2014) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.113.000628 · Cited by 61
Narayanan, M. A., Vakil, K. P., Reddy, Y. N. V., Baskaran, J., Deshmukh, A. J., Benditt, D. G., & Adabağ, S. (2017) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2017.02.006 · Cited by 64
“In appropriately selected patients, CRT reduces both sudden and nonsudden deaths when compared to medical therapy (11,12).”
BackgroundMethodInfluentialSex Differences in Heart Failure
Savarese, G., & D’Amario, D. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-77932-4_32 · Cited by 77
Zweerink, A., Friedman, D. J., Klem, I., van de Ven, P. M., Vink, C. E. M., Biesbroek, P. S., Hansen, S. M., Emerek, K. J. G., Kim, R. J., van Rossum, A. C., et al. (2018) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.118.006767 · Cited by 62
The Treatment of Heart Failure with Reduced Ejection Fraction
Berliner, D., Hänselmann, A., & Bauersachs, J. K. (2020) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2020.0376 · Cited by 78
Subcutaneous Implantable Cardioverter Defibrillator
Rowley, C. P., & Gold, M. R. (2012) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.111.964676 · Cited by 67
Impact of a Novel Adaptive Optimization Algorithm on 30-Day Readmissions
Starling, R. C., Krum, H., Bril, S. L., Tsintzos, S. I., Rogers, T. B., Hudnall, J. H., & Martin, D. O. (2015) · JACC Heart Failure · doi:10.1016/j.jchf.2015.03.001 · Cited by 61
Fung, J. W., Yu, C., Chan, J. Y., Chan, H. C.-K., Yip, G. W., Zhang, Q., & Sanderson, J. E. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.04.053 · Cited by 61
Chung, M. K., Patton, K. K., Lau, C., Forno, A. D., Al‐Khatib, S. M., Arora, V., Birgersdotter-Green, U. M., Cha, Y., Chung, E. H., Cronin, E. M., et al. (2023) · Journal of Arrhythmia · doi:10.1002/joa3.12872 · Cited by 69
Jastrzębski, M., Foley, P. W. X., Chandrasekaran, B., Whinnett, Z. I., Vijayaraman, P., Upadhyay, G. A., Schaller, R. D., Gardas, R., Richardson, T. D., Kudlik, D., et al. (2024) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.124.013059 · Cited by 60
Kolb, C., Sturmer, M., Sick, P. B., Reif, S., Davy, J. M., Molon, G., SCHWAB, J. O., Mantovani, G., Dan, D., Lennerz, C., et al. (2014) · JACC Heart Failure · doi:10.1016/j.jchf.2014.05.015 · Cited by 76
Pathobiology of cardiac dyssynchrony and resynchronization
Kass, D. A. (2009) · Heart Rhythm · doi:10.1016/j.hrthm.2009.08.017 · Cited by 60
Self-citationResponse to Cardiac Resynchronization Therapy in Elderly Patients (≥70 Years) and Octogenarians
Verbrugge, F. H., Dupont, M., Vusser, P. D., Rivero‐Ayerza, M., Herendael, H. V., Vercammen, J., Jacobs, L., Verhaert, D., Vandervoort, P. M., Tang, W. H. W., et al. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs151 · Cited by 60
“History of valvular surgery, n (%) 27 (12) 8 (11) 16 (17) 3 (6) 0.”
Wilton, S. B., Shibata, M. A., Sondergaard, R. E., Cowan, K. F., Semeniuk, L., & Exner, D. V. (2008) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-008-9287-1 · Cited by 60
“35, conduction delay, and highly symptomatic heart failure [1–8].”
BackgroundRisk Factors for Implantable Defibrillator Lead Fracture in a Recalled and a Nonrecalled Lead
Morrison, T. B., Rea, R. F., Hodge, D. O., Crusan, D. J., Koestler, C., Asirvatham, S. J., BRADLEY, D., Shen, W. K., Munger, T. M., Hammill, S. C., et al. (2010) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2009.01683.x · Cited by 60
Kong, M. H., Al‐Khatib, S. M., Sanders, G. D., Hasselblad, V., & Peterson, E. D. (2011) · Cardiology Journal · doi:10.5603/cj.2011.0005 · Cited by 63
Efficacy and Safety of Exercise Training in Patients With Chronic Heart Failure
O’Connor, C. M., Whellan, D. J., Lee, K. L., Keteyian, S. J., Cooper, L. S., Ellis, S. J., Leifer, E., Kraus, W. E., Kitzman, D. W., Blumenthal, J. A., et al. (2017) · Cited by 60
Braunschweig, F., Ford, I., Conraads, V. M., Cowie, M., Jondeau, G., Kautzner, J., Lunati, M., Aguilera, R. M., Yu, C., Marijianowski, M. M. H., et al. (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2008.06.016 · Cited by 62
“However, despite the improvements brought by devices, these patients are still at considerable risk for heart failure hospitalisation or death, as indicated by the annual event rates in the treatment arms reported in large scale heart failure device trials [19–21].”
BackgroundLeft ventricular remodeling after myocardial infarction: past, present, and future.
Tiyyagura, S. R., & Pinney, S. (2006) · PubMed · Cited by 80
Rademakers, L. M., van Gelder, B. M., Scheffer, M. G., & Bracke, F. A. L. E. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.01.031 · Cited by 62
Park, H. E., Chang, S., Kim, H., Shin, D., Kim, J. H., Seo, M.-K., Kim, Y.-J., Cho, G., Sohn, D., Oh, B., et al. (2010) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.109.890848 · Cited by 57
Curtis, A. B., Adamson, P. B., Chung, E. S., Sutton, M. S. J., Tang, F. R., & WORLEY, S. J. (2007) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2007.00907.x · Cited by 63
Hardt, S. E., Yazdi, S. H. F., Bauer, A., Filusch, A., Korosoglou, G., Hansen, A., Bekeredjian, R., Ehlermann, P., Remppis, A., Katus, H. A., et al. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.03.015 · Cited by 59
“Various studies have demonstrated improvement in survival, quality of life, exercise capability and systolic function following initiation of CRT [1–4].”
BackgroundCardiac resynchronization therapy in paediatric and congenital heart disease patients
van der Hulst, A. E., Delgado, V., Blom, N. A., de Veire, N. R. V., Schalij, M. J., Bax, J. J., Roest, A. A. W., & Holman, E. R. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr093 · Cited by 58
Zhang, Q., Fung, J. W., Auricchio, A., Chan, J. Y., Kum, L. C. C., Wu, L. W., & Yu, C. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi885 · Cited by 64
Berger, T., Hanser, F., Hintringer, F., Poelzl, G., FISCHER, G., Modre, R., TILG, B., Pachinger, O. M., & Roithinger, F. X. (2005) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2005.40496.x · Cited by 58
Pappone, C., Ćalović, Ž., Vicedomini, G., Cuko, A., McSpadden, L. C., Ryu, K., Romano, E., Baldi, M., Saviano, M., Pappone, A., et al. (2014) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12513 · Cited by 58
Rocchi, G., Bertini, M., Biffi, M., Ziacchi, M., Biagini, E., Gallelli, I., Martignani, C., Cervi, E., Ferlito, M., Rapezzi, C., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn483 · Cited by 58
Arya, A., Haghjoo, M., Dehghani, M. R., Alasti, M., Alizadeh, H., Kazemi, B., & Sadr‐Ameli, M. A. (2005) · Heart Rhythm · doi:10.1016/j.hrthm.2005.07.007 · Cited by 61
Steffel, J., Milosevic, G., Hürlimann, A., Krasniqi, N., Namdar, M., Ruschitzka, F. T., Lüscher, T. F., Duru, F., Holzmeister, J., & Hürlimann, D. (2011) · Heart · doi:10.1136/heartjnl-2011-300222 · Cited by 59
Interventricular Electrical Delay Is Predictive of Response to Cardiac Resynchronization Therapy
Gold, M. R., Singh, J. P., Ellenbogen, K. A., Yu, Y., Wold, N. D., Meyer, T. E., & Birgersdotter-Green, U. M. (2016) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2016.02.018 · Cited by 58
Emerek, K. J. G., Friedman, D. J., Sørensen, P. L., Hansen, S. M., Larsen, J. M., Risum, N., Thøgersen, A. M., Graff, C., KISSLO, J. A., Søgaard, P., et al. (2018) · Heart Rhythm · doi:10.1016/j.hrthm.2018.08.028 · Cited by 58
Fung, J. W. H., Chan, J. Y. S., Yip, G. W., Chan, H. C.-K., Chan, W. W. L., Zhang, Q., & Yu, C. (2007) · Heart · doi:10.1136/hrt.2007.115295 · Cited by 58
Kinugawa, K. (2011) · Circulation Journal · doi:10.1253/circj.cj-11-0621 · Cited by 57
Ruwald, M. H., Mittal, S., Ruwald, A., Aktaş, M. K., Daubert, J. P., McNitt, S. A., Al‐Ahmad, A., Jøns, C., Kutyifa, V., Steinberg, J. S., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.06.1177 · Cited by 56
Prognostic value of renal function in patients with cardiac resynchronization therapy
Fung, J. W., Szeto, C., Chan, J. Y., Zhang, Q., Chan, H. C.-K., Yip, G. W., & Yu, C. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.11.015 · Cited by 56
Varma, N. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.07.051 · Cited by 57
Kidney Dysfunction and Sudden Cardiac Death Among Women With Coronary Heart Disease
Deo, R., Lin, F., Vittinghoff, E., Tseng, Z. H., Hulley, S. B., & Shlipak, M. G. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.103804 · Cited by 62
Bryant, A. R., Wilton, S. B., Lai, M. P., & Exner, D. V. (2013) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2012.12.003 · Cited by 57
Right, But Not Left, Bundle Branch Block Is Associated With Large Anteroseptal Scar
Strauss, D. G., Loring, Z., Selvester, R. H. S., Gerstenblith, G., Tomaselli, G. F., Weiss, R. G., Wagner, G. S., & Wu, K. C. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.04.060 · Cited by 57
Maines, M., Catanzariti, D., Cemin, C., Vaccarini, C., & Vergara, G. (2007) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-007-9155-4 · Cited by 56
“Despite the remarkable progress of the pharmacologic [1–6] and non-pharmacologic therapy, particularly cardiac resynchronization [7–11], hospitalizations due to heart failure (HF) are constantly increasing and HF is now the most common cause of hospital admission in patients older than 65 [12].”
BackgroundHow should we optimize cardiac resynchronization therapy?
Stanton, T., Hawkins, N. M., Hogg, K. J., Goodfield, N. E. R., Petrie, M. C., & McMurray, J. J. V. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn380 · Cited by 57
“The COMPANION trial employed the device-based Expert Ease for Heart FailureTM algorithm to optimize AV delay but not VV delay.(2) The MUSTIC trial specified Ritter’s formula for optimizing AV delay.”
MethodBertini, M., Höke, U., van Bommel, R. J., Ng, A. C. T., Shanks, M., Nucifora, G., Auger, D., Borleffs, C. J. W., van Rijnsoever, E. P. M., van Erven, L., et al. (2012) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jes290 · Cited by 59
Left ventricular lead location and the risk of ventricular arrhythmias in the MADIT-CRT trial
Kutyifa, V., Zaręba, W., McNitt, S. A., Singh, J. P., Hall, W. J., Polonsky, S., Goldenberg, I., Huang, D. T.-C., Merkely, B. P., Wang, P. J., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs334 · Cited by 57
“There are several risk factors contributing to the occurrence of ventricular tachyarrhythmias, ischaemic events, depressed LV function, increased ventricular wall stress, renal dysfunction and atrial fibrillation.(6,10) Some data also indicate that there is a potential pro-arrhythmic risk of biventricular pacing itsel…”
BackgroundCardiac Sympathetic Reserve and Response to Cardiac Resynchronization Therapy
Cha, Y., Chareonthaitawee, P., Dong, Y.-X., Kemp, B. J., Oh, J. K., Miyazaki, C., Hayes, D. L., Rea, R. F., Asirvatham, S. J., Webster, T. L., et al. (2011) · Circulation Heart Failure · doi:10.1161/circheartfailure.110.959858 · Cited by 57
Outcome of Invasive Electrophysiological Procedures and Gender: Are Males and Females the Same?
Santangeli, P., Biase, L. D., Pelargonio, G., & Natale, A. (2010) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2010.01920.x · Cited by 61
van Bommel, R. J., Mollema, S. A., Borleffs, C. J. W., Bertini, M., Ypenburg, C., Marsan, N. A., Delgado, V., van der Wall, E. E., Schalij, M. J., & Bax, J. J. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.06.060 · Cited by 58
Usefulness of Cardiac Resynchronization Therapy in Patients With Adriamycin-Induced Cardiomyopathy
Rickard, J., Kumbhani, D. J., Baranowski, B. J., Martin, D. O., Tang, W. H. W., & Wilkoff, B. L. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.10.024 · Cited by 57
Ventricular Tachycardia Ablation in Severe Heart Failure
Tzou, W. S., Tung, R. H., Frankel, D. S., Vaseghi, M., Bunch, T. J., Biase, L. D., Tholakanahalli, V. N., Lakkireddy, D., Dickfeld, T. M., SALIARIS, A. P., et al. (2017) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.116.004494 · Cited by 58
Giallauria, F., Cuomo, G., Parlato, A., RAVAL, N. Y., Kuschyk, J., & Coats, A. J. S. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12902 · Cited by 60
VersorgungsLeitlinie, N. (2011) · Cited by 58
JCS/JHRS 2024 Guideline Focused Update on Management of Cardiac Arrhythmias
Iwasaki, Y., Noda, T., Akao, M., Fujino, T., Hirano, T., Inoue, K., KUSANO, K. F., Nagai, T., Satomi, K., Shinohara, T., et al. (2025) · Circulation Journal · doi:10.1253/circj.cj-24-0073 · Cited by 77
2026 ESC Guidelines for the management of heart failure
Køber, L., Adamo, M., Ruwald, A., Tomasoni, D., Anderson, L., Andersson, C., Brugts, J. J., Chioncel, O. D., Donal, E., Ferdinandy, P., et al. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag100 · Cited by 147
Prognostic Benefit of Optimum Left Ventricular Lead Position in Cardiac Resynchronization Therapy
Kydd, A. C., Khan, F. Z., Watson, W. D., Pugh, P. J., Virdee, M., & Dutka, D. P. (2014) · JACC Heart Failure · doi:10.1016/j.jchf.2013.11.010 · Cited by 57
Piccirillo, G., Magnanti, M., Matera, S., Carlo, S. D., Laurentis, T. D., Torrini, A., Marchitto, N., Ricci, R. P., & Magrì, D. (2006) · Translational research · doi:10.1016/j.trsl.2006.02.001 · Cited by 61
Thijssen, J., Borleffs, C. J. W., Delgado, V., van Rees, J. B., Mooyaart, E. A. Q., van Bommel, R. J., van Erven, L., Boersma, E. H., Bax, J. J., & Schalij, M. J. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.038 · Cited by 55
Burkhoff, D., O’Neill, W. W., Brunckhorst, C., Letts, D. P., Lasorda, D., & Cohen, H. A. (2006) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.20796 · Cited by 58
Cardiac resynchronization therapy: history, present status, and future directions.
Jaffe, L. M., & Morin, D. P. (2014) · PubMed Central · Cited by 56
Butler, J., Ezekowitz, J. A., Collins, S. P., Givertz, M. M., Teerlink, J. R., Walsh, M. N., Albert, N. M., Canary, C. A. W., Carson, P. E., Colvin, M. M., et al. (2012) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2012.02.005 · Cited by 63
Self-citationBarison, A., Grigoratos, C., Todiere, G., & Aquaro, G. D. (2015) · Heart Failure Reviews · doi:10.1007/s10741-015-9509-4 · Cited by 56
Leyva, F., Zegard, A., Qiu, T., Acquaye, E., Ferrante, G., Walton, J., & Marshall, H. J. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.007026 · Cited by 56
Ferreira, J. P., Metra, M., Anker, S. D., Dickstein, K., Lang, C. C., Ng, L. L., Samani, N. J., Cleland, J. G. F., van Veldhuisen, D. J., Voors, A. A., et al. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1380 · Cited by 56
Bleeker, G. B., Schalij, M. J., Molhoek, S. G., Boersma, E. H., Paul Steendijk, A., van der Wall, E. E., & Bax, J. J. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.03.091 · Cited by 55
Placement of Transvenous Pacemaker and ICD Leads Across Total Chronic Occlusions
McCOTTER, C. J., Angle, J. F., Prudente, L. A., Mounsey, J. P., Ferguson, J., Dimarco, J., Hummel, J. P., & Mangrum, J. M. (2005) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2005.00203.x · Cited by 56
Heinroth, K. M., Elster, M., Nuding, S., Schlegel, F., Christoph, A., Carter, J., Buerke, M., & Werdan, K. (2007) · EP Europace · doi:10.1093/europace/eum086 · Cited by 55
“Although invasive measurements of CO and other parameters remain the ‘gold standard’ for the evaluation of heamodynamics, they are not suitable for routine follow-up and optimization of CRT device settings because such invasive procedures are unpleasant for the patient and have potentially serious complications.(8,40)…”
MethodSack, S., Wende, C. M., Nägele, H., Katz, A., Bauer, W. R., Barr, C. S., MALINOWSKI, K., Schwacke, H., Leyva, F., Proff, J., et al. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfr089 · Cited by 59
Gold, M. R., Daubert, J., Abraham, W. T., Hassager, C., DINERMAN, J. L., Hudnall, J. H., Cerkvenik, J., & Linde, C. M. (2013) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.113.000570 · Cited by 55
Conduction System Pacing for Cardiac Resynchronisation
Sharma, P. S., & Vijayaraman, P. (2021) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2020.45 · Cited by 56
Wang, Y.-C., Xu, X., Hajra, A., Apple, S. J., Kharawala, A., Duarte, G., Liaqat, W., Fu, Y., Li, W., Chen, Y., et al. (2022) · Diagnostics · doi:10.3390/diagnostics12030689 · Cited by 65
“The algorithm of the supervised random forest algorithm was trained using clinical variables from 481 CRT-P patients and tested on 595 CRT-D patients from the COMPANION trial [77].”
MethodPENN, J., Goldenberg, I., Moss, A. J., McNitt, S. A., Zaręba, W., Klein, H., Cannom, D. S., Solomon, S. D., Barsheshet, A., Huang, D. T.-C., et al. (2011) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2011.02011.x · Cited by 55
Implications and Outcome of Permanent Coronary Sinus Lead Extraction and Reimplantation
Burke, M. C., Morton, J. B., LIN, A. C., TIERNEY, S., Desai, A. D., Hong, T. E., Kim, S. W., Salem, Y. S., Alberts, M., & Knight, B. P. (2005) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2005.40802.x · Cited by 55
Mortality Following Defibrillator Implantation in Patients with Renal Insufficiency
Eckart, R. E., Gula, L. J., REYNOLDS, M. R., Shry, E. A., & Maisel, W. H. (2006) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2006.00550.x · Cited by 54
Truong, Q. A., Januzzi, J. L., Szymonifka, J. D., Thai, W.-E., Wai, B., Lavender, Z. R., Sharma, U. C., Sandoval, R., Grunau, Z., Basnet, S., et al. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.07.007 · Cited by 55
Schmidt, M. U., Brömsen, J., Herholz, C., Adler, K., Neff, F., Kopf, C., & Block, M. S. (2007) · EP Europace · doi:10.1093/europace/eul131 · Cited by 56
A simple infection-control protocol to reduce serious cardiac device infections
Ahsan, S., Saberwal, B., Lambiase, P. D., Koo, C. Y., Lee, S., Gopalamurugan, A. B., Rogers, D. P. S., LOWE, M. D., & CHOW, A. W. C. (2014) · EP Europace · doi:10.1093/europace/euu126 · Cited by 59
Dong, Y.-X., Powell, B. D., Asirvatham, S. J., Friedman, P. A., Rea, R. F., Webster, T. L., Brooke, K. L., Hodge, D. O., Wiste, H. J., Yang, Y.-Z., et al. (2012) · EP Europace · doi:10.1093/europace/eus045 · Cited by 57
Strain Imaging Echocardiography: What Imaging Cardiologists Should Know
López‐Candales, A., & Hernández-Suárez, D. F. (2016) · Current Cardiology Reviews · doi:10.2174/1573403x12666161028122649 · Cited by 63
Billebeau, G., Vodovar, N., Sadoune, M., Launay, J., Beauvais, F., & Solal, A. C. (2017) · European Journal of Preventive Cardiology · doi:10.1177/2047487317705488 · Cited by 61
“These new biomarkers include: (i) Galectin-3 (Gal-3), which is involved in cardiac inflammation and fibrosis16 and is strongly associated with HF development, severity17 and prognosis18; (ii) soluble suppressor of tumorigenicity 2 (sST2), which is involved in cardiac fibrosis and hypertrophy19 and has been associated…”
InfluentialEHRA White Paper: knowledge gaps in arrhythmia management—status 2019
Goette, A., Auricchio, A., Boriani, G., Braunschweig, F., Brugada, J., Burri, H., Camm, A. J., Crijns, H. J. G. M., Dagres, N., Deharo, J., et al. (2019) · EP Europace · doi:10.1093/europace/euz055 · Cited by 61
Cardiac Implantable Electronic Device Therapy in Heart Failure
Hussein, A. A., & Wilkoff, B. L. (2019) · Circulation Research · doi:10.1161/circresaha.118.313571 · Cited by 60
Management of Heart Failure After Cardiac Resynchronization Therapy
Aranda, J. M., Woo, G. W., Schofield, R. S., Handberg, E. M., Hill, J. A., Curtis, A. B., Sears, S. F., Goff, J. S., Pauly, D. F., & CONTI, J. B. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.03.078 · Cited by 58
Impact of race and gender on cardiac device implantations
El‐Chami, M. F., Hanna, I. R., Bush, H., & Langberg, J. J. (2007) · Heart Rhythm · doi:10.1016/j.hrthm.2007.07.024 · Cited by 55
Adamson, P. B., CONTI, J. B., Smith, A. L., Abraham, W. T., Aaron, M. F., Aranda, J. M., Baker, J. H., Bourge, R. C., Warner‐Stevenson, L., & Sparks, B. S. (2007) · Clinical Cardiology · doi:10.1002/clc.20250 · Cited by 56
Barnett, D. B., Phillips, S., & Longson, C. M. (2007) · Heart · doi:10.1136/hrt.2007.127563 · Cited by 55
Tate, C. W., Robertson, A. D., Zolty, R., Shakar, S. F., Lindenfeld, J. M., Wolfel, E. E., Bristow, M. R., & Lowes, B. D. (2007) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2007.07.001 · Cited by 58
Self-citationMangiavacchi, M., Gasparini, M., Faletra, F. F., Klersy, C., Morenghi, E., Galimberti, P., Genovese, L., Regoli, F. D., Chiara, F. D., Bragato, R., et al. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.08.008 · Cited by 59
QRS duration and late mortality in unselected post-infarction patients of the revascularization era
Bauer, A., Watanabe, M., Barthel, P., Schneider, R., Ulm, K., & Schmidt, G. P. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi683 · Cited by 62
Müllens, W., Auricchio, A., Martens, P., Witte, K. K., Cowie, M., Delgado, V., Dickstein, K., Linde, C. M., Vernooy, K., Leyva, F., et al. (2020) · EP Europace · doi:10.1093/europace/euaa411 · Cited by 64
Giraldi, F., Cattadori, G., Roberto, M., Carbucicchio, C., Pepi, M., Ballerini, G., Alamanni, F., Bella, P. E. D., Pontone, G., Andreini, D., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.02.065 · Cited by 55
Response to Cardiac Resynchronization Therapy in Patients with Heart Failure and Renal Insufficiency
ADELSTEIN, E. C., Shalaby, A. A., & Saba, S. (2010) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2010.02705.x · Cited by 53
Maisch, B., & Pankuweit, S. (2012) · Heart Failure Reviews · doi:10.1007/s10741-012-9362-7 · Cited by 55
The Use of Nuclear Imaging for Cardiac Resynchronization Therapy
Chen, J., Boogers, M. M., Bax, J. J., Soman, P., & Garcia, E. V. (2010) · Current Cardiology Reports · doi:10.1007/s11886-010-0086-9 · Cited by 54
“Cardiac resynchronization therapy (CRT), provided by multisite pacing of the right and left ventricles, showed benefits in patients with end-stage HF. The benefits include improved HF symptoms, exercise capacity, quality-of-life score, and left ventricular (LV) function [3-8], as well as mortality benefits, in patient…”
BackgroundHeart failure post-myocardial infarction: a review of the issues
Dargie, H. (2005) · Heart · doi:10.1136/hrt.2005.062018 · Cited by 66
Device Therapy in Heart Failure Patients With Chronic Kidney Disease
Cannizzaro, L., Piccini, J. P., Patel, U. D., & Hernandez, A. F. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.05.024 · Cited by 53
Gender Disparity in the Use of Cardiac Resynchronization Therapy in the United States
Alaeddini, J., Wood, M. A., Amin, M. S., & Ellenbogen, K. A. (2008) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2008.01016.x · Cited by 55
TOMPKINS, C. M., Kutyifa, V., Arshad, A., McNitt, S. A., Polonsky, B., Wang, P. J., Moss, A. J., & Zaręba, W. (2015) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12701 · Cited by 54
Bauer, A., Barthel, P., Müller, A., Ulm, K., Huikuri, H. V., Malík, M., & Schmidt, G. P. (2009) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2009.07.013 · Cited by 56
“Because the mortality rates are comparable to those in patients with LVEF of 30% in whom successful ICD trials exist, such prospective studies seem viable.(1-5) Severe autonomic failure–positive patients are also at high risk to die from nonsudden cardiac death.”
BackgroundResult
Metadata
- Authors
- Bristow, M. R., Saxon, L. A., Boehmer, J., Krueger, S., Kass, D. A., De Marco, T., Carson, P., DiCarlo, L., DeMets, D., White, B. G., DeVries, D. W., & Feldman, A. M.
- Affiliations
- University of Colorado Health (US)
- University of Southern California (US)
- Penn State Milton S. Hershey Medical Center (US)
- Bryan Health (US)
- Johns Hopkins Hospital (US)
- Veterans Health Administration (US)
- Pfizer (United States) (US)
- University of Wisconsin–Madison (US)
- Thomas Jefferson University (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-05-20
- Volume
- 350
- Issue
- 21
- Pages
- 2140-2150
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2130907431
- Cited by
- 5,812
- References
- 22
- Citations by year
- 2026: 80 · 2025: 126 · 2024: 131 · 2023: 179 · 2022: 149 · 2021: 157 · 2020: 196 · 2019: 213 · 2018: 210 · 2017: 265 · 2016: 260 · 2015: 308 · 2014: 276 · 2013: 323 · 2012: 350
- FWCI
- 240.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Emergency Medicine › Cardiac Arrest and Resuscitation
- Keywords
- cardiac resynchronization therapy, implantable cardioverter-defibrillator, advanced chronic heart failure, intraventricular conduction delay, heart failure hospitalization, mortality, cardiomyopathy, QRS duration, pharmacotherapy
- MeSH terms
- Adrenergic beta-Antagonists, Aged, Angiotensin-Converting Enzyme Inhibitors, Chronic Disease, Combined Modality Therapy, Diuretics, Female, Heart Failure, Hospitalization, Humans, Male, Pacemaker, Artificial, Risk, Spironolactone, Defibrillators, Implantable, Ventricular Dysfunction, Left
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.